Comprehensive Center for Pain & Addiction researchers surveyed teens on both sides of the U.S.-Mexico border and found that strong family support can prevent children from using alcohol or drugs.

Comprehensive Center for Pain and Addiction researchers are examining the link between prolactin and endometriosis, a painful condition that affects women.

University of Arizona Health Sciences researchers will continue their study of green light therapy, a promising non-opioid pain relief option.

Tally Largent-Milnes, PhD, who once aspired to be a physician, has carved out an impactful space in the field of migraine research.

People with fibromyalgia may have another treatment option available soon thanks to continuing research at the Comprehensive Center for Pain and Addiction.

A study published in the journal PAIN is the first to show how morphine interacts with toll-like receptor 4 to contribute to pain evolution and bone loss.

Multiday dosing is still available for patients in Arizona.

Todd Vanderah, PhD, has been appointed as a Regents Professor, a title awarded to full professors who have garnered the most distinguished accomplishments in research, teaching, scholarship or creative work.

A University of Arizona Health Sciences study uncovered new ways in which Hsp90-inhibitor drugs in the spinal cord are showing promise as potential pain therapeutics.

Comprehensive Center for Pain and Addiction researchers are studying how electronic stimulation of the brain can break looping pain signals and destructive cravings.